Representation and Medication Use in Juvenile Idiopathic Arthritis

CompletedOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

April 1, 2017

Primary Completion Date

October 1, 2017

Study Completion Date

December 1, 2017

Conditions
Juvenile Idiopathic Arthritis
Interventions
OTHER

Interviews with parents of children with juvenile idiopathic arthritis

Interviews with parents of children with juvenile idiopathic arthritis

OTHER

Interviews with children with juvenile idiopathic arthritis

Interviews with children with juvenile idiopathic arthritis

OTHER

Interviews with Physicians

Interviews with Physicians

Trial Locations (1)

34295

Uhmontpellier, Montpellier

All Listed Sponsors
collaborator

Research department, unknowns, Strategic & innovation consulting, Paris (anthropologists)

UNKNOWN

collaborator

NORDIC pharma (funding)

UNKNOWN

lead

University Hospital, Montpellier

OTHER

NCT03892135 - Representation and Medication Use in Juvenile Idiopathic Arthritis | Biotech Hunter | Biotech Hunter